Stockreport

Incannex Healthcare Inc. Reports Fiscal Full Year 2024 Financial Results and Business Updates [Yahoo! Finance]

Incannex Healthcare Inc.  (IXHL) 
PDF Commenced dosing in the RePOSA Phase 2/3 clinical trial of IHL-42X, an oral investigational treatment for patients with obstructive sleep apnea Received Investigation [Read more]